Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 1:58 PM
Ignite Modification Date:
2025-12-24 @ 1:58 PM
NCT ID:
NCT04697095
Eligibility Criteria:
Inclusion Criteria:
General criteria:
* Male or female older than 50,
* Provide written informed consent,
* Patient affiliated to French social security,
* Maximum sampling volume (care + research) per 30-day period to be adapted according to the weight of the patient
Specific criteria:
Patient presenting in both eyes:
* Either the same type of AMD defined according to the modified international AREDS study (Ferris et al. 2013),
* or early AMD in one eye and atrophic AMD in the other eye, the patient will therefore be defined as being atrophic
* or early AMD in one eye and exudative AMD in the other eye, the patient will therefore be defined as exudative,
* or no retinal pathology (control group).
Exclusion Criteria:
General criteria:
* Patient whose weight is less than 50kg,
* Adult patient under guardianship or curatorship or unable to express consent,
* Person deprived of liberty,
* Patient participating in an ongoing clinical trial during the inclusion visit,
Specific criteria:
* Patient with atrophic AMD in one eye and exudative AMD in the other eye,
* Patient presenting with chronic retinal pathologies other than AMD, defined according to the modified international AREDS study (Ferris et al. 2013) , in the included eye,
* Patient taking systemic drugs with an immunomodulatory action: immunosuppressants, immunomodulators, chemotherapy or corticosteroids,
* Patient with systemic pathologies modifying their immune status,
* Patient with a history of diabetes,
* Patient who had dynamic phototherapy on the included eye.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
15 Years
Study:
NCT04697095
Study Brief:
Protocol Section:
NCT04697095